ENDPOINTS

Is the GLP-1 compounding boom over? Not exactly

We’re about to see what happens when compounding goes from filling a gap left by a supply shortage, to more directly competing with pharma. The end of the semaglutide shortage ...

Feb 25, 2025 - 16:34
 0
Is the GLP-1 compounding boom over? Not exactly
We’re about to see what happens when compounding goes from filling a gap left by a supply shortage, to more directly competing with pharma. The end of the semaglutide shortage ...
Read More

Tags:

Previous Article

New clues to the ‘nailed head ritual’ uncovered in Spain

Next Article

Is There Potential for Life on Europa? We Asked a NASA Expert: Episode 52

Related Posts

After research pivot, Biogen beefs up pipeline with Stoke's late-stage Dravet candidate

After research pivot, Biogen beefs up pipeline with Sto...

Feb 18, 2025  0

GSK follows Pfizer in meningococcal vaccine race with new FDA nod

GSK follows Pfizer in meningococcal vaccine race with n...

Feb 15, 2025  0

Sionna inks $191M IPO for cystic fibrosis pipeline as Aardvark eyes $89M for its own listing

Sionna inks $191M IPO for cystic fibrosis pipeline as A...

Feb 9, 2025  0